Soluble CD30 Measured After Lung Transplantation Does Not Predict Bronchiolitis Obliterans Syndrome in a Tacrolimus/Mycophenolate Mofetil-based Immunosuppressive Regimen

Journal of Heart and Lung Transplantation

Volumn 27, Issue 10, 2008, Pages 1172-1175

  Kwakkel van Erp, Johanna M ^a   Otten, Henny G ^a   Paantjens, Annelieke W M ^a   van Kessel, Diana A ^b   van Ginkel, Walter G J ^a   van den Bosch, Jules M M ^b   van de Graaf, Ed A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CD30 ANTIGEN; CD30 LIGAND; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; BLOOD LEVEL; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MALE; PREDICTION; PRIORITY JOURNAL; SAMPLE;

ADULT; ANTIGENS, CD; ANTIGENS, CD30; BIOLOGICAL MARKERS; BRONCHIOLITIS OBLITERANS; EMPHYSEMA; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFORMED CONSENT; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TACROLIMUS;

EID: 52949124760     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.06.007     Document Type: Article

References (19)

1. Boehler A., and Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 22 (2003) 1007-1018
2. Sharples L.D., McNeil K., Stewart S., and Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 21 (2002) 271-281
3. Estenne M., and Hertz M.I. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 166 (2002) 440-444
4. Falini B., Pileri S., Pizzolo G., et al. CD30 (Ki-1) Molecule-a new cytokine receptor of the tumor-necrosis-factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85 (1995) 1-14
5. Matsumoto K., Terakawa M., Miura K., et al. Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro. J Immunol 172 (2004) 2186-2193
6. Durkop H., Latza U., Hummel M., et al. Molecular-cloning and expression of a new member of the nerve growth-factor receptor family that is characteristic for Hodgkin's disease. Cell 68 (1992) 421-427
7. Cambiaggi A., Cantoni C., Marciano S., et al. Cultured human NK cells express the Ki-1/CD30 antigen. Br J Haematol 85 (1993) 270-276
8. Delprete G., Decarli M., Delios M.M., et al. CD30-mediated signaling promotes the development of human T-helper type 2-like T-cells. J Exper Med 182 (1995) 1655-1661
9. Hansen H.P., Dietrich S., Kisseleva T., et al. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme. J Immunol 165 (2000) 6703-6709
10. Bauwens A.M., van de Graaf E.A., van Ginkel W.G.J., van Kessel D.A., and Otten H.G. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 25 (2006) 416-419
11. Susal C., Pelzl S., Dohler B., and Opelz G. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 13 (2002) 1650-1656
12. Frisaldi E., Conca R., Magistroni P., et al. Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation. Transplantation 81 (2006) 1153-1156
13. Pelzl S., Opelz G., Daniel V., Wiesel M., and Susal C. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 75 (2003) 421-423
14. Langan L.L., Park L.P., Hughes T.L., et al. Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. Am J Transplant 7 (2007) 847-856
15. Fields R.C., Bharat A., Steward N., et al. Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 82 (2006) 1596-1601
16. Golocheikine A., Fields R., Angaswamy N., et al. Soluble CD30 may represent a novel marker to monitor the development of bronchiolitis obliterans syndrome following human lung transplant. Am J Transplant 7 (2007) 415
17. Weimer R., Susal C., Yildiz S., et al. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: Impact of different immunosuppressive regimens. Am J Transplant 6 (2006) 1865-1874
18. Hachem R.R., Yusen R.D., Chakinala M.M., et al. A randomized, controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant 26 (2007) 1012-1018
19. O'Neill J.O., Edwards L.B., and Taylor D.O. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 25 (2006) 1186-1191